Group One Trading
RCUS icon

Group One Trading’s Arcus Biosciences RCUS Stock Holding History

Group One Trading’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.39M Sell
156,900
-15,800
-9% -$341K 0.01% 1603
2025
Q4 		$4.12M Buy
172,700
+132,500
+330% +$2.7M 0.01% 1676
2025
Q3 		$547K Buy
40,200
+29,900
+290% +$311K ﹤0.01% 3621
2025
Q2 		$83.8K Sell
10,300
-10,400
-50% -$88.8K ﹤0.01% 5132
2025
Q1 		$162K Buy
20,700
+12,700
+159% +$147K ﹤0.01% 4191
2024
Q4 		$119K Sell
8,000
-1,300
-14% -$21.2K ﹤0.01% 4368
2024
Q3 		$142K Sell
9,300
-29,800
-76% -$470K ﹤0.01% 3902
2024
Q2 		$595K Buy
39,100
+9,600
+33% +$155K ﹤0.01% 2408
2024
Q1 		$557K Buy
29,500
+3,200
+12% +$55.3K ﹤0.01% 2624
2023
Q4 		$502K Sell
26,300
-62,500
-70% -$999K ﹤0.01% 3064
2023
Q3 		$1.59M Buy
88,800
+55,300
+165% +$1.11M 0.01% 1842
2023
Q2 		$680K Buy
33,500
+30,500
+1,017% +$581K ﹤0.01% 2714
2023
Q1 		$54.7K Sell
3,000
-9,100
-75% -$174K ﹤0.01% 4783
2022
Q4 		$250K Buy
12,100
+11,800
+3,933% +$325K ﹤0.01% 3671
2022
Q3 		$8K Sell
300
-200,400
-100% -$5.3M ﹤0.01% 6643
2022
Q2 		$5.09M Buy
200,700
+200,100
+33,350% +$4.9M 0.01% 1280
2022
Q1 		$19K Sell
600
-4,100
-87% -$137K ﹤0.01% 6787
2021
Q4 		$190K Buy
4,700
+3,900
+488% +$151K ﹤0.01% 5140
2021
Q3 		$28K Buy
800
+100
+14% +$3.11K ﹤0.01% 6968
2021
Q2 		$19K Sell
700
-200
-22% -$5.71K ﹤0.01% 7223
2021
Q1 		$25K Sell
900
-100
-10% -$3.48K ﹤0.01% 6660
2020
Q4 		$26K Sell
1,000
-100
-9% -$2.42K ﹤0.01% 5376
2020
Q3 		$19K Sell
1,100
-1,300
-54% -$29K ﹤0.01% 5157
2020
Q2 		$59K Buy
+2,400
New +$64.8K ﹤0.01% 4255

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Group One Trading's RCUS Position: Q4 2025 in Review

Group One Trading sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 130,449 shares — an estimated $2.66M sold.

Group One Trading first reported a position in RCUS in Q4 2020 and held it in 14 quarters. The position peaked at $2.42M in Q3 2024. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Group One Trading reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 130,449 Arcus Biosciences shares in Q4 2025, an estimated $2.66M.
  • Group One Trading first reported a position in Arcus Biosciences in Q4 2020 and held it in 14 quarters.
  • Group One Trading's Arcus Biosciences position peaked at $2.42M in Q3 2024.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.